Preventive strategies for mental health by Arango, Celso et al.
  
Celso Arango, Covadonga M. Díaz-Caneja, Patrick 
McGorry, Judith Rapoport, Iris E. Sommer, Jacob A. 
Vorstman, David McDaid, Oscar Marín, Elena Serrano-
Drozdowskyj, Robert Freedman and William Carpenter 
Preventive strategies for mental health 
 
Article (Accepted version) 
(Refereed) 
 
 
 
Original citation: 
Arango, Celso and Diaz-Caneja, Covadonga M. and McGorry, Patrick and Rapoport, Judith and 
Sommer, Iris E. and Vorstman, Jacob A. and McDaid, David and Marin, Oscar and Serrano-
Drozdowskyj, Elena and Freedman, Robert and Carpenter, William (2018) Preventive strategies 
for mental health. The Lancet Psychiatry. ISSN 2215-0366 (In Press) 
DOI: 10.1016/S2215-0366(18)30057-9 
 
© 2018 Elsevier Ltd. 
 
This version available at: http://eprints.lse.ac.uk/88090/ 
Available in LSE Research Online: May 2018 
 
LSE has developed LSE Research Online so that users may access research output of the 
School. Copyright © and Moral Rights for the papers on this site are retained by the individual 
authors and/or other copyright owners. Users may download and/or print one copy of any 
article(s) in LSE Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities 
or any commercial gain. You may freely distribute the URL (http://eprints.lse.ac.uk) of the LSE 
Research Online website.  
 
This document is the author’s final accepted version of the journal article. There may be 
differences between this version and the published version.  You are advised to consult the 
publisher’s version if you wish to cite from it. 
 
 
 
  1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This is a pre-copyedited, author-produced version of an article accepted for publication in The 
Lancet Psychiatry following peer review.  
 
The final version is available online at:  
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(18)30057-9/abstract  
 
 
Citation: 
Arango C, Díaz-Caneja CM, McGorry PD, Rapoport J, Sommer IE, Vorstman JA, McDaid D, Marín O, 
Serrano-Drozdowskyj E, Freedman R, Carpenter W. Preventive strategies for mental health. Lancet 
Psychiatry. 2018 May 14. pii: S2215-0366(18)30057-9. doi: 10.1016/S2215-0366(18)30057-9.  
 
 
DOI: https://doi.org/10.1016/S2215-0366(18)30057-9   
  2 
PREVENTIVE STRATEGIES FOR MENTAL HEALTH 
Celso Arango, MD
1
,
 
Covadonga M. Díaz-Caneja, MD
1
, Patrick McGorry, PhD
2
, Judith 
Rapoport, MD
3
,
 
Iris E. Sommer, PhD
4
, Jacob A. Vorstman, PhD
5
, David McDaid, PhD
6
, Oscar 
Marín, PhD
7,8
, Elena Serrano-Drozdowskyj, PhD
1
, Robert Freedman, MD
9
, William Carpenter, 
MD
10
 
1. Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio 
Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM. Calle Ibiza 43, 
28009 Madrid, Spain 
2. Orygen Youth Health Research Centre, Centre for Youth Mental Health, Department of 
Psychiatry, University of Melbourne, 35 Poplar Road Parkville, VIC 3052, Australia 
3. Child Psychiatry Branch, NIMH, 10 Center Drive Building 10, Bethesda, MD 20892-1600, 
USA 
4. Department of Neuroscience, University Medical Center Groningen, Groningen, Netherlands 
5. Department of Psychiatry and Program in Genetics and Genome Biology, Research Institute, 
The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada 
6. Department of Health Policy at the London School of Economics and Social Science, London 
WC2A 2AE, UK 
7. Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and 
Neuroscience, King’s College London, London SE1 1UL, UK 
8. MRC Centre for Neurodevelopmental Disorders, King’s College London, London SE1 1UL, 
UK 
9. Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO 80045, 
USA 
  3 
10. Department of Psychiatry, University of Maryland School of Medicine, Maryland 
Psychiatric Research Center, P.O. Box 21247, Baltimore, MD 21228, USA 
 
Location of work and address for reprints: Department of Child and Adolescent Psychiatry, 
Hospital General Universitario Gregorio Marañón. Calle Ibiza 43, 28009 Madrid, Spain 
 
Corresponding author: 
Name: Covadonga M. Díaz-Caneja 
Address: Calle Ibiza 43, 28009 Madrid, Spain 
E-mail: covadonga.martinez@iisgm.com  
Telephone: +34 914265005 
Fax: +34 914265004  
  4 
ABSTRACT 
Current treatment modalities have shown a limited effect on the burden associated with mental 
disorders. We review promising universal, selective, and indicated preventive mental health 
strategies that may reduce the incidence of mental disorders or shift expected trajectories to less 
debilitating outcomes. Some of these interventions also seem to be cost-effective. In the 
transition to mental illness, the cumulative lifetime effect of multiple small-effect-size risk 
factors progressively increases vulnerability to mental disorders. This may inform different 
levels and stages of tailored interventions to lessen risk or increase protective factors and 
resilience, especially during sensitive developmental periods. Gaps between knowledge, policy, 
and practice need to be bridged. Future steps should include more emphasis on mental health 
promotion and improvement of early detection and interventions in clinical settings, schools, 
and the community, with essential support from society and policymakers. 
Key words: child psychiatry, adolescents, community mental health, epidemiology, outcome 
studies, economics, prevention, promotion. 
 
Key messages panel: 
 There is increasing evidence supporting the efficacy of some universal and selective 
preventive interventions to promote mental wellbeing and prevent mental disorders 
throughout development.  
 Indicated prevention in those showing sub-threshold manifestations of vulnerability can 
shift expected trajectories towards less debilitating outcomes or delay the onset of 
severe mental disorders. 
 Ethical and safety considerations should guide the implementation of preventive 
interventions in mental health, especially in young people and at-risk populations.     
 Mental health professionals should incorporate a focus on prevention into their daily 
practice and work in close cooperation with other specialties (primary care, obstetrics, 
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paediatrics) and sectors (education, social services) to increase awareness of the 
evidence base for preventive interventions in mental health.   
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Introduction 
While there is increased interest in early detection to prevent progression to severe mental 
disorders such as schizophrenia and recurrent major depression, knowledge of risk factors and 
developmental trajectories has not yet been widely applied to clinical practice and public 
health.
1
 Psychiatry has traditionally been based on treatment and prevention of progression and 
disability in individuals with established illness (i.e. tertiary prevention). Although a number of 
medical specialties have joined forces with public education and health associations to reduce 
risk factors for diseases such as myocardial infarction,
2
 preventive initiatives in mental health 
have received far less attention. Scientific evidence gathered from other areas of medicine, 
along with increasing knowledge of developmental risk factors preceding psychiatric illness and 
preliminary findings supporting preventive interventions, indicate that our field could move 
toward the more ambitious goals of universal prevention of vulnerability, selective prevention 
in high-risk subgroups and indicated prevention of full or more severe expression of illness in 
those already showing early manifestations.
3
 The reality is that, of all mental health research 
funding, less than 5% goes to prevention research, even in countries that have actually invested 
in prevention.
4
  
In this narrative review, we will first summarize the various possibilities for mental health 
prevention throughout development and the evidence supporting them. We will then review the 
potential limitations currently associated with these approaches and potential ways to overcome 
them.  
 
1. Prevention in mental health  
Prevention in mental health aims at reducing the incidence, prevalence, and recurrence of 
mental disorders and their associated disability. Preventive interventions are based on 
modifying risk exposure and strengthening the coping mechanisms of the individual.
5
 Effective 
interventions require identifying causal risk factors
6
 and can target both generic risk factors, 
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which are likely to be shared by different disorders, and disease-specific factors. Most 
preventive programmes will likely involve a combination of strategies for reducing exposure to 
risk factors, enhancing protective factors, and targeting putative mediating causal mechanisms 
such as cognitive schemas or neurotransmitter imbalances. Primary preventive interventions in 
mental health are those targeting risk factors and promoting mental health in individuals without 
a clinically diagnosable mental disorder. Such interventions may target a whole population 
regardless of individual risk (universal prevention), a subpopulation known to be at increased 
risk for mental illness (selective prevention), or individuals already showing sub-threshold 
clinical manifestations (indicated prevention).
5
 Table 1 provides an overview of the different 
kinds of preventive interventions in mental health with examples of each. This review will focus 
mostly on primary preventive interventions.  
 
Risk factors increasing vulnerability to mental disorders 
Mental disorders have different degrees of heritability, pathogenic genetic variation being a 
major risk factor for multiple mental disorders.
7
 The cumulative effect of multiple common 
alleles of small effect or the relatively high impact of rare pathogenic variants, in interaction 
with environmental risk factors, increases the risk for development of mental disorders.
8
 This is 
also true for environmental risk factors. Although some rare environmental risk factors might 
have large effect sizes, most environmental risk factors are characterized by small effect sizes 
and seem to increase susceptibility but are not sufficient to explain the occurrence of a 
disorder.
8
 They include but are not limited to prenatal environment (e.g. poor nutrition, 
exposure to drugs or toxins, maternal infections or stress), birth complications, preterm delivery, 
brain trauma, social risks (e.g. socio-economic disadvantage and poverty, urbanicity, 
immigration, social isolation), trauma (e.g. parental neglect, physical, emotional, and sexual 
abuse, bullying), lack of stimulation, general adversity and stressful life events, and drug abuse 
(see Figure 1).
9-12
 Many of these risk factors are interrelated and tend to cluster and have 
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synergistic effects. For example, immigration often co-occurs with urbanicity and social 
disadvantage,
13
 while children who have been exposed to violence are at higher risk of repeated 
victimization.
14
 Subjects with mental disorders or disabilities and those who have already been 
exposed to risk factors may be less capable of defending themselves and seem to be more often 
targeted by bullies and abusers.
15
 Therefore, once vulnerable, it is more likely that further risk 
factors may lead to a vicious cycle. This “facilitation effect” is also supported by epigenetic 
changes found in the serotonin transporter and glucocorticoid receptor genes of victims of child 
trauma and their subsequent neuroendocrine alterations and changes in brain structure and 
function.
16
 These neurobiological changes may lead to maladaptive responses to stress, thus 
increasing vulnerability to stress-related diseases and feeding lifetime revictimization.
16
 
Identification of specific risk and protective factors for mental disorders is challenging because 
of person-environment interactions and correlations. Individuals are not passive recipients of 
events inasmuch as they process their experiences according to their personal history and social 
environment, and this influences their ability to adapt to these events and may modify how they 
interact with the environment to shape and select their future experiences.
17
 Interaction with the 
environment is also subject to genetic influence; genetic factors may affect the sensitivity of the 
individual to particular environmental risks and contexts (i.e. gene-environment interactions)
8
 
and modulate exposure to certain risk and protective factors (i.e. gene-environment 
correlations).
19
 Furthermore, exposure to the environment and life events, as well as 
interventions (both pharmacological and psychosocial), can induce biological changes at 
different levels (e.g. epigenetics, neurotransmitters, brain connectivity), thus modifying the 
ability to adapt to further stressors. This complicates the picture but also affords an opportunity 
for different levels of intervention (biological, psychological, family-related, social 
environment) at different developmental stages to lessen risk or increase protective factors. 
Opportunities for prevention during development 
a) Mental disorders as “multiple-hit” developmental disorders 
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It is usually the cumulative effect of risk and lack of protective factors during development that 
leads to a transition from health to mental illness.
20
 Even if early risk factors (e.g. genetic risk or 
early environmental factors such as severe deprivation) are present, in the absence of additional 
“hits”, a disorder ultimately may not develop. This has been shown to be especially important in 
the development of disorders such as schizophrenia and bipolar disorder
21
 and offers a unique 
opportunity for targeted prevention in high-risk individuals by reducing exposure to further risk 
factors and enhancing protective factors.
9
 Among the possible additional risk factors, bullying 
victimization has been strongly associated with short- and long-term vulnerability to mental 
illness.
11
 Interestingly, ceasing exposure to bullying and maltreatment during childhood has 
been shown to reduce the incidence of psychotic experiences after 12 months.
22
 Effective 
strategies to reduce bullying such as school-based anti-bullying programmes have also proved 
effective in reducing subsequent aggression or internalizing problems in adolescents.
23
 
Similarly, strategies such as providing comprehensive educational and family support to 
economically disadvantaged children could be effective in preventing other risk factors such as 
child abuse, with one study reporting a reduction in its incidence among participants by 52%.
24
 
Even when there is a “first hit” or further “hits”, the effect could be lessened by enhancing 
protective factors such as family and social support and promoting resilience.
25
 Resilience is a 
multidimensional construct that can be conceptualized as the ability to adapt well after 
experiencing adversity, trauma, or other stressors.
25
 A number of effective interventions have 
been developed to promote resilience, especially in children and adolescents.
26
 Their core 
elements include enhancing social and emotional competence skills and promoting self-efficacy, 
adaptability, and social connectedness in young people, as well as fostering positive parenting 
and facilitating family communication and problem-solving.
26
 For instance, in children exposed 
to risk factors such as low birthweight or bullying, a positive family environment has been 
found to increase resilience to these risk factors.
27,28
 Although the essential approach for 
bullying prevention entails intervening in community and school factors that foster bullying 
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behaviour, family interventions and other strategies to promote individual resiliency may be 
helpful in improving outcomes in those who have already been victimised.
29
  
b) Developmental pathways of vulnerability to mental ill-health 
From a developmental psychopathology perspective, mental disorders appear to be the result of 
a dynamic process of repeated environmental maladaptation leading to progressive deviation 
from normative development. Multiple pathways can lead to similar manifest outcomes, while 
the same deviant developmental pathway can lead to different psychopathological outcomes. 
Although change may be constrained to some extent by prior adaptation, especially during 
sensitive periods, the pluripotentiality of early trajectories of vulnerability suggests that change 
is possible at many points during development.
30
 This is also compatible with a staging model 
similar to models developed in other areas of medicine, which suggests that severe mental 
disorders develop from at-risk preclinical states, then pass through undifferentiated general 
symptoms, followed by increasing clinical specificity and functional decline.
31
  
Both perspectives lead to an optimistic outlook for a preventive approach, inasmuch as it would 
be possible to intervene in the developmental process of any mental condition or shift the 
psychopathological expression towards less debilitating disorders, by intervening in people with 
risk factors or already showing subtle abnormal development.
32
 Early risk markers of 
developmental deviance that can precede severe disorders in adulthood include subtle language 
and motor delays, extreme temperament traits, irritability, sub-threshold hyperactivity and 
conduct problems, low cognitive performance, decline in IQ, and social difficulties in 
childhood.
33-35
 These signs could help characterize subpopulations with increased 
developmental vulnerability to guide targeted intensive interventions. 
There are several examples that suggest that it may be feasible to change trajectories toward a 
less severe mental disorder or a less severe form of a given disorder. Psychosocial interventions 
in subjects at clinical high risk (CHR) for psychosis, such as cognitive-behavioural therapy 
(CBT), may lead to a reduction in transition rates to psychosis or a delay of onset and 
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amelioration of debilitating symptoms.
36
 Although based on a single study that warrants 
replication, there is also very preliminary evidence suggesting that early intervention in toddlers 
diagnosed with autism spectrum disorder may improve functionality and diminish core 
symptoms of the disorder.
37 
Another example is attention deficit hyperactivity disorder 
(ADHD). Treatment with stimulants in childhood may improve or stabilize social functioning 
and academic performance in ADHD. Subsequently, the rate of secondary drug abuse, conduct 
disorders, and social problems may decrease in adolescence and adulthood, stopping a potential 
downward spiral.
38
 Similarly, there is evidence suggesting that reducing the duration of anxiety 
or depressive episodes in young people may prevent the development of more severe mental 
disorders during adulthood.
39
 
c) Sensitive periods for prevention in mental health 
During a lifespan, there are sensitive periods where risk and protective factors may have greater 
impact and long-lasting consequences.
16,40
 These periods include the prenatal period, childhood, 
and adolescence through early adulthood (see Figure 1). It may not be coincidental that the 
windows of vulnerability largely overlap with periods of major developmental brain changes, 
such as maturation of several receptors, myelination, pruning, and development of hub 
regions.
40
 These periods are also crucial for development of secure attachment, basic schemas 
related to self, others, and the world, self-esteem and self-integrity, and finally the adult 
personality, and overlap with the peak incidence of major mental disorders.
41
 Prevention 
focusing on these periods may be more effective and have long-lasting benefits.  
There is emerging evidence that the prenatal environment may shape gene expression related to 
foetal brain development and thus affect the risk of mental disorders.
42
 Therefore, providing 
appropriate screening and care for factors such as maternal nutrition and substance abuse 
including smoking, and parental mental disorders and stress during this period could 
considerably contribute to global prevention of mental disorders in children.
43,44
 In the postnatal 
period and early childhood, exposure to stressors, such as child abuse, neglect, or malnutrition 
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may interfere with the development of brain regions critical to regulation of emotion and lead to 
poorer mental and physical health.
16
 Thus, reducing child abuse rates and improving early 
family and social environments could decrease lifetime mental disorders.
45
 During adolescence, 
strategies to prevent substance abuse and other risky behaviours, and to promote healthy 
lifestyles and positive coping mechanisms could be especially useful.
26,46
  
Despite the numerous opportunities for prevention in mental health, there are some specific 
factors that may hamper the advancement of prevention in psychiatry and should be considered 
when designing and implementing interventions. Panel 1 shows an overview of these factors 
and potential ways to overcome some of these difficulties.  
 
2. Evidence supporting primary prevention in psychiatry 
2.1. Universal preventive interventions  
Universal prevention of mental disorders addresses generic risk and protective factors in the 
general population. Such interventions are likely to affect the global probability of developing 
psychiatric and other disorders in a non-specific fashion. A holistic approach to health, 
integrating psychosocial and physical aspects of wellbeing, may be especially valuable in this 
regard. A recent meta-analysis of 67 cluster trials reported that the World Health Organization 
(WHO) Health Promoting School framework, a school-based programme using this approach, 
has significant positive effects on physical activity, physical fitness, body weight, fruit and 
vegetable intake, tobacco use, and bullying. The authors’ interpretation was that, despite the 
small effect sizes, these interventions could have public health benefits at the population level.
47
 
There are also data suggesting that promoting healthy lifestyles, including appropriate nutrition 
and regular exercise, could have positive effects on cognitive development, scholastic 
achievement, and mental health vulnerability.
5,48
 Something as simple as eating dinner as a 
family may serve as a venue for parents to promote coping strategies that offset the impact of 
stressful environmental factors, such as cyber-bullying.
49
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Schools play a central universal prevention role in childhood and adolescence. There are a 
number of effective school-based anti-bullying programmes that reduce bullying rates, on 
average by ~20%,
50
 and may reduce related mental health symptoms.
23
 Universal school-based 
programmes may also be effective in improving social and emotional skills, attitudes, 
behaviour, and academic performance, as suggested by a meta-analysis assessing 213 
programmes involving more than 270,000 students from kindergarten through high-school.
51
 
School-based programmes using self-regulation change techniques could also improve self-
esteem and internalizing behaviour in adolescents, with small effect sizes (~0·20).
52
  
Additional key targets for universal prevention include the prenatal and perinatal periods. 
Recent studies suggest that dietary phosphatidylcholine supplementation during the second and 
third trimesters may prevent cerebral inhibition deficits associated with schizophrenia and 
attention deficit disorder.
53
 There is also evidence suggesting that vitamin D supplementation 
during pregnancy may reduce rates of low birthweight and preterm delivery,
54
 which have been 
associated with attention deficits and increased risk for childhood behavioural and emotional 
disorders.
55,56
. Similarly, preliminary data suggest that vitamin D supplementation during the 
first year of life may reduce the incidence of schizophrenia in males.
57
 Other strategies to 
improve maternal nutrition (fortification or supplementation) may be associated with reduced 
obstetric complication rates and improved behavioural outcomes in offspring.
58
 Interventions to 
promote effective parenting in expectant or new parents can also have positive effects on the 
cognitive, social, and motor development and mental health of the child.
59
  
There is evidence based on meta-analyses and systematic reviews that some psychosocial 
universal preventive interventions are effective for anxiety and depression,
60,61
 eating 
disorders,
62
 and substance use disorders in young people.
46
 Restriction of access to lethal means 
and school-based awareness programmes have been found to significantly reduce suicidality.
63
 
There is also preliminary evidence suggesting that additional supplementation strategies (e.g. N-
acetylcysteine, sulphoraphane, probiotics) constitute promising strategies for universal 
prevention in mental health that merit further research in the coming years.
64
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2.2 Selective preventive interventions 
Children of parents with mental illness or substance use disorders represent one of the 
populations at highest risk for psychiatric problems.
65
 In children at high familial risk for 
psychosis, about 10% will develop psychosis and 50% non-psychotic problems.
33,65
 Similarly, 
offspring of depressed parents have a threefold higher risk of developing anxiety disorders, 
major depression, and substance dependence.
66
 Genetic vulnerability aside, there are several 
studies that attribute childhood risk to parental mental health status, suggesting that successful 
management of parental psychopathology could improve outcomes in their offspring. A meta-
analysis indicates that preventive interventions targeting mentally ill parents could reduce the 
risk of mental disorders in their offspring by 40%.
67
  
Other at-risk populations include children with genetic disorders associated with an increased 
risk for early developmental deficits and psychiatric symptoms. In these at-risk populations, 
universal school- or community-based preventive interventions against bullying and abuse may 
be especially helpful to prevent mental disorders, by reducing exposure to these frequent risk 
factors. Selective preventive interventions in at-risk populations should target social stress and 
emotional problems, promote resilience, and facilitate early identification and access to services 
in those already in need of care.
9
 Compensatory approaches to social and cognitive problems 
could provide additional benefits to interventions aimed at improving resilience in these 
populations.
68
 
There is also evidence supporting the efficacy of some psychosocial selective interventions to 
prevent externalizing disorders in children reared in disadvantaged environments,
69
 or exposed 
to violence within the family context,
70
 post-traumatic stress disorder (PTSD) in children and 
adolescents exposed to traumatic events,
71
 eating disorders in young people belonging to high-
risk groups (e.g. female athletes or adolescents with body image issues),
62
 postpartum 
depression,
72
 and depression and/or anxiety disorders in young offspring of patients with 
depressive disorders
73
 and other high-risk populations,
60,74
 as well as of some pharmacotherapy 
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strategies (e.g. hydrocortisone) to prevent PTSD.
75
 Most of the effective interventions had small 
to medium effect sizes relative to control conditions.   
 
2.3. Indicated preventive interventions 
Indicated preventive interventions are those conducted in individuals showing subthreshold 
manifestations of mental disorders. Interventions in these subgroups may be more efficient, 
since they minimize the number of individuals who need to be exposed to the intervention and 
target individuals who may already be in need of care. Some meta-analyses suggest that 
indicated interventions could have greater effect sizes than universal ones (e.g. programmes for 
eating disorders or depression),
61,62,76
 although this is not a consistent finding, and several meta-
analyses report no significant differences or even greater effect sizes for universal 
interventions.
60
 Examples of effective indicated interventions supported by meta-analyses 
include parent management training to prevent externalizing disorders in children with high 
antisocial behaviour scores,
77
 and to prevent depression and anxiety disorders in children 
showing early manifestations of internalizing disorders.
78
 CBT in CHR subjects may lead to a 
reduction in transition rates to psychosis.
79
 There is also evidence that CBT-based strategies 
may be effective for preventing chronic PTSD in patients showing early acute stress symptoms 
after exposure to a traumatic event
80
 and eating disorders in young people showing subthreshold 
symptoms.
62
 CBT and interpersonal therapy may be also effective for prevention of depression 
and/or anxiety in young people and adults presenting with subclinical symptoms.
76,81
  
 
3. Is it worth investing in mental health prevention?  
Despite mounting scientific data supporting the efficacy of early intervention and prevention in 
psychiatry, there still is a gap between research evidence and clinical and public health 
practices. Can this be attributed to economics? All in all, the accumulated evidence suggests 
that improving long-term outcomes and reducing some of the long-term adverse consequences 
  16 
of poor mental health (e.g. secondary disorders, criminality, unemployment) make many early 
mental health interventions cost-effective for society,
9,82
 especially in light of the high direct and 
indirect costs generated by neuropsychiatric disorders, which are responsible for 14% of the 
global burden of disease (disability-adjusted life years) worldwide.
83
 Recently, the European 
Observatory on Health Systems and Policies, the Organization for Economic Co-operation and 
Development, and the WHO Regional Office for Europe have compiled data demonstrating that 
influencing risk behaviours for chronic non-communicable diseases, including mental disorders, 
is an efficient use of government money and that government policies can have a major impact 
on risk behaviours for mental disorders.
84
 
For example, in the UK, it was calculated that for every US dollar spent on mental health 
promotion and prevention, ten-year total societal returns on investment, (including impacts on 
health and other sectors, such as education and the criminal justice system) were $83·73 for 
whole-school conduct disorder prevention and $10·27 for early detection services in people 
with prodromal symptoms of psychosis.
82
 A recent estimate of the benefits of preventing 
bullying suggests a conservative return of between $10·67 and $16·79 per dollar invested by 
age 21 due to higher earnings and better educational outcomes, with other savings likely due to 
avoided adult depression.
85
 Similarly, there could be substantial savings when investing in 
home-visiting programmes for disadvantaged pregnant women,
86
 early intensive behavioural 
interventions in pre-school children with autism,
87
 interventions to reduce truancy and school 
exclusion,
88
 parenting interventions to prevent internalizing
89
 or externalizing disorders in 
children,
77
 and early intervention services for early-onset psychosis in children and 
adolescents.
90
 There is also evidence supporting the cost-effectiveness of interventions to 
prevent the neuropsychiatric consequences of prenatal risk factors, such as folic acid 
fortification of enriched cereal-grain products for the prevention of neural tube deficits
91
 and 
universal screening in pregnancy for subclinical hypothyroidism.
92
 For conditions such as 
maternal depression and suicidal behaviour, there may be benefits to individuals, relatives, and 
society of improving the ability of professionals to detect and intervene in at-risk and early 
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stages.
93,94
 The promotion of health literacy in routine educational settings may also be cost-
effective for a wide range of health, educational, and social outcomes.
95
 Table 2 provides a 
summary of the cost-effectiveness analysis of key examples of primary preventive interventions 
in psychiatry.  
Compared with other medical conditions, savings in psychiatry may be greater. Debilitating 
mental disorders usually have a much earlier onset than many other chronic diseases, increasing 
the number of years that health and social welfare services and caregiver support will be 
needed, hence the potential savings from prevention. Whereas 50% of mental disorders start 
before 14 years of age and 75% before the age of 24,
41
 the mean age at onset of diabetes is 53·8 
years
96
 and the average age of a first heart attack in US men is 65.
97
 Therefore, it is reasonable 
to assume that the direct and indirect savings (e.g. higher rates of employment and higher 
earnings when employed) to society from early and long-lasting reduction of the burden of 
mental illness would be much higher than for many other chronic medical conditions. 
Furthermore, considering the bidirectional relationship between mental and physical health, 
influencing risk factors for psychiatric disorders could also help prevent other medical 
conditions in adulthood. For example, bullying victimization has been associated with an 
increased future risk of a number of inflammatory disorders.
11
 Interventions to prevent bullying 
are likely to have an impact on the development of both psychiatric and medical disorders, as 
well as non-medical outcomes (e.g. educational attainment and societal benefits).  
In light of this evidence, two recent initiatives in the US
98
 and Europe
99
 have included 
prevention among the top priorities for mental health research. The US group emphasizes that it 
is feasible to achieve these priorities in the next ten years, but only if funding begins 
immediately.
98
 And the clock has already started ticking… 
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4. Current role of mental health professionals in mental health prevention 
Some of the general factors that can potentially increase the risk for reduced psychological 
wellbeing and psychiatric disorders, such as social exclusion or economic inequality, cannot be 
directly addressed by psychiatrists. Universal interventions in the general population require a 
public mental health approach and will probably be delivered by other medical specialties such 
as obstetrics and general practice or other sectors such as education. We believe that it is the 
duty of mental health professionals to increase awareness among the general public, politicians, 
and policymakers about the importance of mental health prevention and promotion and about 
the evidence supporting cost-effective interventions. Mental health professionals should start 
incorporating an at-risk-oriented focus into our clinical practice by improving current 
definitions for early clinical stages, enhancing screening instruments, developing targeted 
interventions, and promoting training in prevention for all mental health professionals. The role 
of clinicians may be especially important for selective and indicated interventions, by providing 
care to those already at risk, in whom periodic specialized monitoring of subsequent mental 
problems may be especially useful. Strengthening the coordination between child/adolescent 
and adult psychiatric services targeting the same areas could be especially valuable to facilitate 
management of the offspring of patients with major mental disorders and to assist with the 
transition through services in other high-risk populations. This could be especially useful, 
considering the often large treatment gap during the transition from child/adolescent to adult 
services.
100
 Improving access to care in those already in need may constitute an excellent 
secondary and tertiary preventive strategy, by reducing duration of untreated illness and its 
negative consequences. Considering the high comorbidity and bidirectional association of 
mental disorders with somatic conditions, coordination with primary care is also essential. Panel 
2 provides specific details on some key areas of mental health prevention that we believe should 
be prioritized in the coming years.   
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Conclusions 
Increasing evidence suggests that there are feasible and safe preventive interventions in 
psychiatry that could translate into a broader focus on prevention in our field. Many preventive 
interventions in mental health may be cost-effective or even cost-saving. There is evidence 
supporting the efficacy of some universal, indicated, and selective prevention strategies for 
improving psychological wellbeing or preventing mental disorders throughout development. 
The search for further scientific evidence on the efficacy and cost-effectiveness of preventive 
interventions is warranted. Nevertheless, despite incomplete evidence for some universal 
interventions, there are public health prevention strategies in other areas of medicine for which 
evidence was acquired only after universal adoption (e.g. folic acid supplementation, fluoride 
treatment, and measles vaccine). These set the example for moving forward with safe 
interventions for which there is initial evidence for efficacy in advance of empirical proof of 
mental disorder prevention, especially considering the potential two-decade gap between 
implementation of early preventive strategies and emergence of mental disorders.  
Investigation of early stages of mental disorders integrating different dimensions (genetic, 
transcriptomic, neurobiological, psychological, socio-economic), including their complex 
interactions throughout early developmental periods, is needed. Further evidence should be 
gathered on the optimization of different intervention strategies based on developmental timing, 
while also factoring in potential short- and long-term benefits beyond mental health outcomes 
(educational, functional, societal). As there is a need to prioritize these interventions, we 
propose that implementation in the area of mental health could start in children with factors 
known to increase the risk for developing a mental disorder (e.g. children of parents with major 
mental disorders, children with genetic risks known to increase incidence of mental disorders) 
or those showing nonspecific symptomatic manifestations of the early stages of mental 
disorders or indicators of early developmental deviation. To achieve these goals, the support of 
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society and public policymakers is essential. Disseminating the potential societal benefits of 
evidence-based findings may increase community awareness and stimulate inclusion of cost-
effective prevention programmes for mental disorders in political agendas.  
 
 
Search strategy and selection criteria 
References for this narrative, critical review were identified through PubMed searches for 
articles and previous reviews published through December 2016 using the key terms 
“prevention”, “high-risk”, “risk factors”, “promotion”, “resilience”, “development”, “staging”, 
and “early intervention” in combination with the terms “psychiatry”, “mental health”, and 
“psychopathology”. Articles identified by these searches that related to the main topics covered 
in the manuscript and relevant references cited in those articles were selectively reviewed. We 
conducted an additional systematic PubMed search from inception through November 2017 to 
identify meta-analyses assessing primary preventive interventions for specific mental conditions 
[i.e. mood disorders (depression, bipolar disorder), anxiety disorders, post-traumatic stress 
disorder, externalizing disorders (disruptive behaviour disorders (i.e. conduct disorders, 
oppositional-defiant disorder), attention-deficit hyperactivity disorder), eating disorders, 
psychotic disorders, autism spectrum disorders, and suicidal behaviour] (see Supplemental 
Material for additional details). These references were systematically reviewed and the most 
recent or comprehensive meta-analyses supporting universal, selective, or indicated preventive 
interventions for each disorder were included in the manuscript. Complementary searches were 
performed in Google Scholar and PubMed to identify examples of cost-effectiveness studies on 
preventative interventions in psychiatry.  
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Figure 1: Risk factors for mental disorders in sensitive periods of intervention 
 
 
 
Abbreviations: ADHD: attention deficit hyperactivity disorder; ASD: autism spectrum 
disorders; CBT: cognitive-behavioural therapy; HR: high risk; IPT: interpersonal therapy; IQ: 
intelligence quotient; SNV: single nucleotide variant; CNV: copy number variation   
 
 
 
 
 
 
 
Ri
sk
 F
ac
to
rs
Genetic  ● Positive family history of mental disorders (65, 66)
 ● Clinically significant SNV or CNV such as 22q11.2 deletion (101)
Biological  ● Maternal infection (102) 
 ● Preterm birth and obstetric 
complications  (55, 103)
 ● Poor nutrition (43)
 ● Exposure to drugs & 
medications (44)
 ● Brain trauma (104)
 ● Physical health (105)
 ● Epigenetic changes in 
serotonin and glucocorticoid 
transporters, changes in brain 
structure and function (16)
 ● Brain & hormonal changes 
(106)
 ● Substance abuse (107)
 ● Physical health (105)
Family-related  ● Perinatal depression (108)  ● Parental neglect (10)
 ● Child maltreatment (10, 45)
 ● Parental mental illness (65, 66)
Society  ● Bullying and other forms of 
abuse (11)
 ● Lack of proper stimulation (109)
 ● Bullying and other forms of 
abuse (11)
 ● Social adversity: socio-economic disadvantage, stressful urban 
environments, immigration, social isolation (12, 13, 110)
 ● Stigma (111)
Pr
ev
en
tiv
e 
In
te
rv
en
tio
ns
General 
Population
 ● Reducing income inequality and unemployment (114)
 ● Improving education and child care (24, 115)
 ● Reducing social stigma (111)
 ● Increasing societal and professional awareness (116)
 ● Pregnancy care (86) 
 ● Nutrition (43)
 ● Phosphatidylcholine 
supplementation (53)
 ● Promotion of bonding (117)
 ● Informative genetic 
counselling (118) 
 ● Proper stimulation for 
developmental stage (119)
 ● Family dinners (49)
 ● School academic 
achievement, social climate, 
resiliency skills (24, 26)
 ● Anti-bullying interventions in 
schools (23, 50) 
 ● Nutrition and physical 
exercise (48)
 ● Having dinner with minors (49)
 ● School academic 
achievement, social climate, 
resiliency skills (24, 26)
 ● Anti-bullying interventions in 
schools (23, 50)
 ● Nutrition and physical 
exercise (48)
 ● Prevention of substance 
use (46) 
At-Risk 
Population
 ● Improving support for 
disadvantaged adolescents 
pregnant for the first time (86) 
 ● Maternal mental illness: close 
monitoring of physical and 
mental state, substance and 
medication use (108, 120) 
 ● Improving parental mental 
state (67)
 ● Early intensive intervention for 
ASD (37)
 ● Parent training for 
externalizing and internalizing 
problems (77, 78)
 ● Secondary prevention 
with stimulants of ADHD 
complications (38) 
 ● Psychological interventions 
(e.g. CBT, IPT, other) for 
indicated prevention in young 
people with subclinical 
symptoms (76, 78-81)
 ● Cognitive remediation and 
improving social skills for 
selective prevention in some 
HR groups (9, 68)
Ea
rly
 D
et
ec
tio
n 
& 
Ri
sk
 M
ar
ke
rs
 ● Screening for family history of mental disorders (65, 66)
 ● Screening for maternal 
psychiatric disorders (108)
 ● Screening for genetic variants 
associated with increased 
risk for neurocognitive and /or 
psychiatric phenotypes (101)
 ● Screening for postnatal 
depression or parental 
psychiatric illness (108)  
 ● Screening and surveillance 
of developmental trajectories 
(112)
 ● Delayed or altered develop-
mental milestones (33, 
112): cognitive, language, 
psychomotor, social, 
academic performance
 ● Chronic irritability and 
hyperactivity (34, 35) 
 ● Cognitive decline (9)
 ● Altered social behaviour or 
poor academic performance 
(33)
 ● Psychotic-like experiences (9)
 ● Brain and blood biomarkers 
(113): accelerated loss of 
frontal cortical grey matter 
and greater expansion of third 
ventricle, inflammation and 
oxidative stress
Conception
Puberty
Adolescence
Late Teens
& Twenties
ChildhoodBirth
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Table 1: Definitions of preventive interventions in mental health  
 
 Target population Aims Examples 
Mental health promotion interventions General public or whole population 
 
 Promote psychological wellbeing and increase the 
ability to achieve developmental milestones 
 Strengthen abilities to adapt to adversity and build 
resilience and competence 
School-based programmes to foster 
healthy eating or positive coping 
skills 
Universal primary preventive interventions General public or whole population, 
regardless of individual risk factors 
 Target risk factors in the whole population to 
prevent the development of one or more conditions 
 Interventions should be effective, safe, and 
associated with low costs.   
School-based programmes to 
prevent bullying 
Selective primary preventive interventions Individuals or subpopulation with a 
significantly higher than average risk of 
developing mental disorders  
 
The identification of these risk groups may 
be based on biological, psychological, or 
social risk factors 
 Target risk factors and strengthen abilities in these 
individuals or subpopulations to prevent the 
development of one or more conditions 
 Interventions should be effective and associated 
with low risk of adverse events and moderate 
costs.  
Interventions in the offspring of 
patients with severe mental 
disorders 
Indicated primary preventive interventions Individuals at high-risk showing early 
minimal but detectable clinical 
manifestations but currently not meeting 
diagnostic criteria 
 
 Treat subclinical manifestations to prevent 
transition to the full-blown disorder  
 Target risk factors and strengthen abilities in these 
individuals to promote resilience 
 Interventions may be associated with higher costs 
and some risks can be accepted.  
Interventions in subjects at clinical 
high-risk for psychosis (i.e. showing 
attenuated psychotic symptoms and 
a recent decline in functioning)  
Secondary preventive interventions Individuals meeting diagnostic criteria in the 
early stages of illness 
 Early detection and intervention in patients 
already meeting diagnostic criteria for a specific 
mental disorder  
 Provide adequate treatment, improve satisfaction 
with treatment, reduce substance use and prevent 
relapses  
Interventions to improve early 
detection and access to services in 
patients with depression to reduce 
duration of untreated depression 
Tertiary preventive interventions Individuals with established illness  Treat established disease to prevent deterioration, 
disability, and secondary conditions 
Interventions for smoking cessation 
and cognitive remediation in 
patients with schizophrenia 
Prevention of suicide with lithium in 
patients with bipolar disorder  
 
It should be noted that there is some overlap between indicated primary preventive interventions and secondary preventive interventions. Universal primary 
preventive interventions will frequently employ mental health promotion strategies.   
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Table 2: Key examples of primary preventive interventions in mental health 
 
Intervention Sources of evidence Efficacy results 
Cost-effectiveness data 
(2016 US dollars) 
Preventive strategies for postpartum 
depression 
Meta-analysis 
Systematic review 
RCTs 
~20% reduction in rates of maternal depression 
during the first months after birth
72
 
Improvement in mother-infant interaction and child 
developmental functioning  
Reduction of child abuse and neglect
120
 
Universal preventive interventions found to be most 
effective in reducing 12-month depression scores 
(Edinburgh Postnatal Depression Scale) were 
midwifery redesigned postnatal care, person-
centred approach interventions, and cognitive 
behavioural therapy-based interventions
121
 
In the UK, home health interventions were 
associated with cost of ~$7,281 to $7,928 per 
quality-adjusted life year gained as compared 
with routine care.
82,94
 In Canada, trained 
telephone peer support had a 95% chance of a 
cost per case of averted maternal depression of 
less than $17,446.
122
 These examples are 
conservative since long-term impacts on child, 
siblings and fathers are not considered. 
A more recent study in Australia suggests that 
psychoeducation may also be cost-effective in 
preventing postpartum depression and 
anxiety.
123
 
Parent training for prevention of 
behavioural disorders 
Meta-analysis 
Systematic review 
RCTs 
Reduction in child conduct problems
77
 
Improvement in parental mental health, reduction in 
negative and harsh parenting practices
77
 
60% of program investment recovered due to 
costs averted within 2 years and 100% in 5 
years
77
 
Cost savings after 8 years and total savings over 
25 years of at least $15,028 from public purse 
and societal perspective
82
 
School-based interventions to 
prevent bullying 
Meta-analysis 
Systematic review 
RCTs 
~20% reduction in rates of peer victimization
50
 
Reduction in aggression and internalizing 
symptoms
23
 
In the UK, a universal programme would show 
cost savings after 3 years and generate expected 
mid-term return on investment through reduced 
health costs, improved education outcomes, and 
likely higher earnings of $10.67 to $16.79 per 
dollar invested per pupil by age 21. Further 
savings due to likely reduced rate of adulthood 
depression.
85
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Panel 1: Factors that hamper the advancement of prevention in psychiatry  
a. Limitations of using diagnoses of specific mental disorders as outcome measures of preventive 
interventions 
There do not seem to be silos of risk or protective factors for current clinical diagnoses. Whether at 
the level of aetiology
7
 or pathophysiology,
124
 these factors seem to increase or decrease vulnerability 
to many mental disorders. Even in genetic conditions such as 22q11.2 deletion syndrome, there is 
remarkable pleiotropy, and the outcome is highly variable in terms of functionality, intellectual 
disability, and psychiatric diagnosis. This is true for almost all copy number variations associated with 
psychiatric conditions.
101
 Therefore, there do not seem to be fixed pathways leading to each specific 
DSM or ICD defined disorder.
30,32
 Although some interventions may be more specific (e.g. some 
indicated interventions), this implies that many public health interventions, whether population-wide 
or in a high-risk subgroup, may have low specificity and reduce incidence or improve outcomes 
across disorders. Quantification of the effectiveness of such interventions should therefore be 
reflected by global measures of disorders and include other kinds of outcomes (education, wellbeing, 
social and legal services, etc.). For mental illness, in many instances, there is the additional problem 
of a two-decade delay from birth to emergence of a specific disorder.   
b. Barriers to identification and care in those at-risk  
In the absence of reliable biomarkers for mental disorders, it is very difficult to predict future illness 
in individuals and reliably identify subpopulations at risk for specific disorders. The difficulties 
involved in identifying those at highest risk are exacerbated by the fact that families most in need of 
intervention (e.g. disadvantaged) may have the least access to care. Further research should be done 
on the early stages of mental disorders with the aim of identifying potential psychological, biological, 
and social risk markers.  
c. Methodological and ethical challenges of preventive interventions 
Preventive strategies are associated with some intrinsic difficulties such as the high number of 
potentially false positive treatments and the high costs that can be associated with interventions in 
larger populations. Considering the potential for ineffective or even iatrogenic interventions, it is 
crucial to conduct rigorous research on preventive interventions. Since a high proportion of the 
population that is not necessarily at risk could be exposed to these kinds of interventions, safety 
should guide the implementation of primary universal interventions. In this concern, strategies to 
promote mental wellbeing, healthy eating, and physical activity, reduce bullying and other forms of 
child abuse, and improve workplace conditions are associated with very low risks and could be 
prioritized. Supplementation strategies (e.g. vitamin D) during pregnancy or the neonatal period 
should be further studied considering their potential risks. However, increasing evidence suggesting 
an association of reduced vitamin D during pregnancy and the neonatal period with 
neurodevelopmental disorders,
125
 with preliminary data suggesting a beneficial effect of vitamin D 
supplementation on birth outcomes in the offspring,
54
 and low risk of side effects
54
, indicate that they 
could be carefully implemented, at least in high-risk subpopulations (i.e. pregnant women or neonates 
with vitamin D levels in the lowest percentiles). Low sensitivity to identify those with subthreshold 
symptoms could also limit indicated preventive interventions. For instance, it has been estimated that 
well-established clinical high-risk (CHR) services may miss 95% of those who will develop a 
psychotic disorder.
64
  
Implementing early-stage detection and intervention strategies in a clinical context for indicated and 
selective prevention has clear ethical implications. It seems feasible (and critically important) to 
identify people at high risk for whom health systems are equipped to provide proper care (e.g. young 
people showing mild symptoms or behaviours suggestive of CHR and healthy individuals with known 
genetic risk). While disclosure in these instances may be beneficial for both patient and family, by 
providing understanding and perspective and offering advice for reducing risk, promoting resilience, 
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and orienting future actions in case of progression, this process may also be stressful and raise 
concerns regarding stigma. Disclosure should be done with great caution not to decrease self-esteem 
and hopes or aims for the future. Rather, interventions in at-risk individuals should be framed as 
encouragement for a better future. Safety should guide clinical decision-making in those identified as 
being at risk, and lower-risk interventions should be prioritized, especially in young people.  
d. Long-term benefits do not seem to motivate health authorities or political decisions 
Lack of awareness of the significant economic savings from preventive interventions for mental 
disorders, the need for an initial investment in training and investment of time by professionals, often 
with no short-term return, and stigma partly explain the lack of interest in mental health prevention as 
compared with other areas of medicine. It may take more time to realize the benefits of investing in 
prevention in mental health than in other areas of medicine (e.g. oncology or cardiovascular disease). 
This is problematic when politicians need to prioritize their health actions based on what can be 
communicated to future voters in four- to five-year election cycles. A focus on prevention and public 
health requires a long-term view, which is sometimes not possible for politicians due to their short 
terms in office and frequent shifts in priorities and main lines of intervention in health and education 
when a different party comes to power, sometimes without regard for the beneficial effect of previous 
approaches. National and international funding agencies could play an essential role in providing the 
required long-term support to appropriately evaluate and implement preventive interventions. In 
addition, prevention and early detection of mental disorders may be perceived as more complex than 
in other areas of medicine, as there is a false perception that mental disorders are not associated with 
mortality, and resources are more easily directed toward health conditions that are considered fatal, 
especially in the short term. To overcome these difficulties, politicians and the society should become 
aware of the high morbidity and mortality associated with mental disorders
126
 and the economic return 
on investment of mental health research, which is similar to research in cardiovascular disease.   
Some preventive interventions may be delivered by sectors other than healthcare. Support and funding 
from other institutions, including education authorities, may be required for improving health literacy 
and developing interventions targeting children and adolescents, especially in schools. An economic 
argument can be made to employers to try to motivate them to proactively intervene to reduce stress 
and improve working environments in their companies. This means that information and research on 
potential short-term benefits of interventions needs to look beyond impacts on the health system (e.g. 
for school-related outcomes such as academic achievement, reduced truancy, and teacher stress, or 
potential employer benefits of improved worker mental health) to involve these additional sectors in 
this process, which also opens opportunities for additional sources of funding and support.  
e. Challenge of rebalancing investment in prevention and treatment of mental disorders 
Even though the costs associated with some preventive interventions are not necessarily high, in a 
context of tight healthcare budgets, choices and trade-offs are required between investment in 
prevention and investment in treatment of existing conditions. This is where mid- to long-term cost-
effectiveness arguments could be made. This is also applicable to other areas of medicine where effect 
sizes and cost-effectiveness data have not been more robust than for mental health. Multi-sectorial 
investment also becomes feasible if economic benefits to other sectors, e.g. education, can also be 
identified. 
f. Stigma 
General stigmatisation of mental illness implies an underestimation of the need for prevention in 
psychiatry on the part of the general population. The risk of a heart attack seems plausible to most of 
us, but many will not believe they need to be protected against suicide or self-harm. Personal and 
community stigma and lack of insight could also hinder indicated prevention in people with early 
manifestations of mental illness to a greater extent than in other medical conditions by delaying help-
seeking behaviour and care due to anticipated discrimination.
111
 Evidence-based interventions to 
tackle stigma and improving access to care in those already experiencing mental distress should be 
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prioritized. 
g. Additional factors 
Additional factors include: i) limited insurance coverage in some countries, ii) the need for multilevel 
and multi-sectorial intervention when services are usually compartmentalized, iii) low perception of 
risk when early manifestations of mental ill-being are subtle, especially in children and adolescents, 
iv) high variability of behavioural manifestations during infancy and adolescence, and v) paucity of 
validated screening tools and treatment for conditions first evident in infants. These factors should be 
considered when designing preventive interventions (see Panel 2).  
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Panel 2: Takeaways for prevention of mental disorders 
 
1. Translating scientific evidence about cost-effective preventive interventions into public health 
initiatives, clinical practice, and service delivery systems.  
 
2. Increasing social, professional, and political awareness about advancements and the importance 
of mental health prevention and promotion.  
 
This includes social education campaigns about early signs, risk and protective factors, and 
consequences of mental disorders. Claims for societal health investment in preventive psychiatry 
should be based on personal, family, health, education, and social benefits of reducing mental 
illness burden, as well as on long-term and indirect economic savings of mental health prevention 
programmes by reducing disability. 
 
3. Moving clinical practice toward at-risk-oriented detection and intervention.  
 
a. Need for clearer and more specific definitions of early clinical stages incorporating 
neuroimaging, neurocognitive, and biochemical markers into the description of cases, 
which may help monitor possible trajectories and detect new therapeutic targets.  
 
b. Providing standardized and cost-effective screening measures for the accurate detection 
of at-risk populations at early stages of development such as perinatal mental illness, 
developmental disorders, subjects at high risk for psychosis, and children of parents with 
severe mental illness. There is particularly a need to develop screening tools with high 
sensitivity, specificity, and positive predictive value for toddlers and pre-schoolers. 
 
c. Procuring standardized and cost-effective preventive interventions such as caring for 
pregnant adults and adolescents, parental training programmes, cognitive-behaviour 
therapy and other psychosocial interventions (for high-risk subjects).  
 
d. Promoting proper training in standardized and cost-effective preventive interventions for 
professionals. Since professionals will detect the risk, they should acquire skills for 
communicating probability and managing related stress in parents and patients facing 
uncertainty. In this regard, any decision-making should be based on evidence regarding 
risks and benefits. 
 
4. Providing interventions designed for each developmental stage aimed at minimizing the impact of 
risk factors. 
   
5. Promoting interventions with a multidisciplinary and multi-level (psychological, social, familial, 
legal) approach. This will require improving coordination among different institutions.  
 
6. Promoting healthy life styles including nutrition and exercise. 
 
7. Encouraging school interventions (targeting children, parents, and education professionals) for: 
a. Early detection of deviation from normal psychomotor development, language delays, 
abnormal social behaviour, and poor academic performance 
b. Reduction of bullying 
c. Protection and promotion of resilience to peer victimization and abuse in the vulnerable 
and assistance for victims, abusers, and bystanders 
d. Prevention of health risk behaviours, including substance abuse and suicidality, and 
related burden 
e. Promotion of mental and physical health  
 
 1 
SUPPLEMENTAL MATERIAL 
 
Supplemental Methods 
 
A complementary systematic search of meta-analyses assessing primary preventive 
interventions for specific mental disorders [i.e. mood disorders (depressive disorders, bipolar 
disorder), anxiety disorders, post-traumatic stress disorder, externalizing disorders (disruptive 
behaviour disorders (i.e. conduct disorders, oppositional-defiant disorder), attention-deficit 
hyperactivity disorder (ADHD)), eating disorders, psychotic disorders, autism spectrum 
disorders, and suicidal behaviour] was conducted in PubMed from inception through 6 
November 2017. A list of the search terms is provided below. We reviewed meta-analyses 
reporting pooled data for preventive interventions for specific mental disorders, not within a 
medical condition or targeting specific professional groups. We incorporated into the 
manuscript the most recent or comprehensive references for each kind of preventive 
intervention (universal, selective or indicated) for each specific mental disorder. Studies 
assessing both therapeutic and preventive interventions were reviewed only if they provided 
separate statistical data for the preventive interventions. Studies assessing general mental health 
outcomes (such as wellbeing or resilience) were not included in this review, but if relevant, their 
results were incorporated into the general manuscript. With respect to suicidality, we did not 
review interventions for the secondary prevention in people with mental disorders (e.g. lithium 
in patients with mood disorders, antidepressants in patients with major depression). No specific 
meta-analyses were found assessing primary preventive interventions in ADHD, obsessive-
compulsive disorder, autism spectrum disorders or bipolar disorder.  
 
 
Disorder Mental disorder terms Prevention terms 
Depression Depression 
Depress* 
Internalizing 
Prevention 
Preventive 
Preventative 
Universal 
Indicated 
Selective 
Bipolar disorder Bipolar disorder 
Affective psychosis 
Anxiety disorders Anxiety  
Phobia 
Anxi*  
Obsessive  
Compulsive 
OCD  
Panic 
Agoraphobia 
Internalizing 
Post-traumatic stress 
disorder 
PTSD  
Post-traumatic stress disorder 
Posttraumatic stress disorder 
Acute stress disorder 
Psychotic disorders Psychosis 
Schizophrenia 
ADHD ADHD 
Attention-deficit/ hyperactivity disorder 
Attention deficit hyperactivity disorder  
ADD  
Attention deficit disorder  
 2 
Attention-deficit hyperactivity disorder 
Other externalizing 
disorders 
Conduct disorder  
Disruptive behaviour disorder 
Callous 
Antisocial 
Oppositional defiant 
Externalizing 
Suicidality Suicide 
Suicid*  
Self-harm 
Eating disorders Eating disorder 
Bulimia  
Anorexia 
Autism spectrum 
disorders 
Autism  
Austist* 
Asperger 
 
 
